Narváez Javier, Palacios-Olid Judith, García de Yebenes María Jesús, Holgado Susana, Olivé Alejandro, Casafont-Solé Ivette, Castañeda Santos, Valero-Martínez Cristina, Martín-López María, Carreira Patricia E, Mora-Limiñana Maribel, Nuño-Nuño Laura, Robles-Marhuenda Angel, Bernabeu Pilar, Campos José, Graña Jenaro, Ortiz-Santamaria Vera, Camacho-Lovillo Marisol, Vargas Carmen, Sanchez-Manubens Judith, Anton Jordi
Department of Rheumatology, Hospital Universitario de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.
Instituto de Salud Musculoesquelética, 28045 Madrid, Spain.
J Clin Med. 2025 Jan 6;14(1):285. doi: 10.3390/jcm14010285.
To investigate the prevalence and clinical spectrum of atypical or non-classical complications in adult-onset Still's disease (AOSD) beyond macrophage activation syndrome (MAS) and to identify factors linked to their occurrence. Multicenter cross-sectional study of AODS cases included in the Spanish registry on Still's disease. This study included 107 patients (67% women), of whom 64 (59.8%) developed non-classical complications. These include macrophage activation syndrome in 9.5%, atypical skin manifestations in 38.8%, cardiac involvement in 22.7% (comprising pericarditis, myocarditis, pulmonary arterial hypertension, and noninfectious endocarditis), pleuritis in 28.9%, transient pulmonary infiltrates in 4%, significant headache in 14.1%, lower abdominal pain with evidence of peritonitis in 8.4%, and secondary amyloidosis in 0.9%. In the multivariate logistic regression analysis, lymphadenopathy (OR 2.85, 95% CI 1.03-7.91, = 0.044) and the systemic score system (SSC) index (OR 1.86, 95% CI 1.29-2.69, = 0.001) were independently associated with the development of non-classical clinical manifestations. In contrast, typical exanthema was associated with a reduced risk of these complications (OR 0.32, 95% CI 0.11-0.95, = 0.041). In addition to the typical clinical manifestations and MAS, a significant proportion of patients with AOSD develop uncommon complications, some of which can be potentially life-threatening. These should be considered in the evaluation and follow-up of patients. Early recognition and prompt management are crucial to significantly reduce morbidity and mortality.
旨在调查成人斯蒂尔病(AOSD)中除巨噬细胞活化综合征(MAS)之外的非典型或非经典并发症的患病率及临床谱,并确定与其发生相关的因素。对纳入西班牙斯蒂尔病登记处的AODS病例进行多中心横断面研究。本研究纳入了107例患者(67%为女性),其中64例(59.8%)出现了非经典并发症。这些并发症包括9.5%的巨噬细胞活化综合征、38.8%的非典型皮肤表现、22.7%的心脏受累(包括心包炎、心肌炎、肺动脉高压和非感染性心内膜炎)、28.9%的胸膜炎、4%的短暂性肺部浸润、14.1%的严重头痛、8.4%有腹膜炎证据的下腹部疼痛以及0.9%的继发性淀粉样变。在多因素逻辑回归分析中,淋巴结病(比值比[OR] 2.85,95%置信区间[CI] 1.03 - 7.91,P = 0.044)和系统评分系统(SSC)指数(OR 1.86,95% CI 1.29 - 2.69,P = 0.001)与非经典临床表现的发生独立相关。相比之下,典型皮疹与这些并发症的风险降低相关(OR 0.32,95% CI 0.11 - 0.95,P = 0.041)。除了典型临床表现和MAS外,相当一部分AOSD患者会出现不常见的并发症,其中一些可能危及生命。在患者评估和随访中应考虑到这些情况。早期识别和及时处理对于显著降低发病率和死亡率至关重要。